+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Phenobarbital"

Anticonvulsants Global Market Report 2024 - Product Thumbnail Image

Anticonvulsants Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Sleep Disorder Treatment Drugs Markets in China - Product Thumbnail Image

Sleep Disorder Treatment Drugs Markets in China

  • Report
  • February 2024
  • 227 Pages
  • China
From
Sleep Disorder Treatment Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Sleep Disorder Treatment Drugs Industry Forecasts - China Focus

  • Report
  • February 2024
  • 114 Pages
  • China
From
From
From
From
2020 Phenobarbital Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations - Product Thumbnail Image

2020 Phenobarbital Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations

  • Report
  • February 2020
  • Japan, United States, ... Japan, United States, Europe
From
From
Antiepileptic Drugs Market - Forecast (2022 - 2027) - Product Thumbnail Image

Antiepileptic Drugs Market - Forecast (2022 - 2027)

  • Report
  • January 2022
  • 137 Pages
  • Global
From
The Treatment of Epilepsy. 3rd Edition - Product Thumbnail Image

The Treatment of Epilepsy. 3rd Edition

  • Book
  • July 2009
  • 1116 Pages
  • 14 Results (Page 1 of 1)
Loading Indicator

Phenobarbital is a central nervous system drug used to treat seizures and insomnia. It is a barbiturate, a type of drug that acts as a sedative-hypnotic. It is also used to treat alcohol withdrawal and to prevent seizures in people with epilepsy. Phenobarbital is available in both generic and brand-name forms. It is typically taken orally, but can also be administered intravenously. Common side effects include drowsiness, dizziness, and confusion. Phenobarbital is one of the oldest and most widely used anticonvulsant drugs. It is used to treat a variety of seizure disorders, including generalized tonic-clonic seizures, partial seizures, and status epilepticus. It is also used to treat insomnia and alcohol withdrawal. The phenobarbital market is a part of the larger central nervous system drugs market. This market is driven by the increasing prevalence of neurological disorders, such as epilepsy, Alzheimer's disease, and Parkinson's disease. The market is also driven by the increasing demand for generic drugs, as well as the development of new drugs to treat neurological disorders. Some companies in the phenobarbital market include Pfizer, GlaxoSmithKline, Sanofi, Novartis, and Mylan. Show Less Read more